RU94022663A - Derivatives of 2-mercaptobenzimidazole having selective anxyolytic activity - Google Patents

Derivatives of 2-mercaptobenzimidazole having selective anxyolytic activity

Info

Publication number
RU94022663A
RU94022663A RU94022663/04A RU94022663A RU94022663A RU 94022663 A RU94022663 A RU 94022663A RU 94022663/04 A RU94022663/04 A RU 94022663/04A RU 94022663 A RU94022663 A RU 94022663A RU 94022663 A RU94022663 A RU 94022663A
Authority
RU
Russia
Prior art keywords
derivatives
mercaptobenzimidazole
compounds
anxyolytic
activity
Prior art date
Application number
RU94022663/04A
Other languages
Russian (ru)
Other versions
RU2061686C1 (en
Inventor
С.Б. Середенин
Ю.А. Бледнов
В.А. Савельев
Т.Я. Можаева
Х.С. Рагимов
М.А. Яркова
Original Assignee
Научно-исследовательский институт фармакологии РАН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-исследовательский институт фармакологии РАН filed Critical Научно-исследовательский институт фармакологии РАН
Priority to RU94022663/04A priority Critical patent/RU2061686C1/en
Priority to DE69528843T priority patent/DE69528843T2/en
Priority to US08/750,369 priority patent/US6376666B1/en
Priority to JP50199296A priority patent/JP3559045B2/en
Priority to PCT/RU1995/000085 priority patent/WO1995034304A1/en
Priority to EP95918794A priority patent/EP0788795B1/en
Publication of RU94022663A publication Critical patent/RU94022663A/en
Application granted granted Critical
Publication of RU2061686C1 publication Critical patent/RU2061686C1/en
Priority to KR1019960707153A priority patent/KR970703765A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FIELD: medicine. SUBSTANCE: desired products have common formulawhere n= 0,2,3; R is allyl, dialkylamino- or nitrogen-containing heterocycles, Rand Rare the same or different and represent H, lower alkyls and alkoxy. Desired derivatives are prepared by alkylation of 2-mercaptobenzimidazoles with appropriate alkylating agent. The process is followed by treatment thus prepared bases with hydrogen chloride. Said derivatives or their pharmaceutically acceptable salts has anxyolytic action and are low toxic. EFFECT: creates novel derivatives of 2-mercaptobenzimidazole having selective anxyolytic activity.

Claims (1)

Изобретение относится к новым биологически активным соединениям - производным 2-меркаптобензимидазола общей формулы
Figure 00000001

где n = 0, 2, 3; R - аллил, диалкиламино или азотсодержащие гетероциклы; R1 и R2 - одинаковые или различные, водород, низшие алкилы, алкокси, и их фармацевтически приемлемым солям, обладающим анксиолитической активностью. Целью изобретения является создание новых соединений в ряду 2-меркаптобензимидазола, обладающих селективной анксиолитической активностью при низкой токсичности. Цель достигается синтезом заявляемых соединений путем алкилирования 2-меркаптобензимидазолов соответствующими алкилирующими агентами с последующей обработкой образующихся оснований хлористым водородом. По данным проведенного психофармакологического скрининга по общепринятой схеме заявляемые соединения в широком диапазоне доз обладают выраженным анксиолитическим действием, которое не сопровождается побочными седативным, снотворным, миорелаксантным эффектами. Заявляемые соединения имеют низкую токсичность.
The invention relates to new biologically active compounds - derivatives of 2-mercaptobenzimidazole of the General formula
Figure 00000001

where n = 0, 2, 3; R is allyl, dialkylamino or nitrogen-containing heterocycles; R 1 and R 2 are the same or different, hydrogen, lower alkyls, alkoxy, and their pharmaceutically acceptable salts having anxiolytic activity. The aim of the invention is the creation of new compounds in the series of 2-mercaptobenzimidazole with selective anxiolytic activity with low toxicity. The goal is achieved by the synthesis of the claimed compounds by alkylation of 2-mercaptobenzimidazoles with appropriate alkylating agents, followed by treatment of the resulting bases with hydrogen chloride. According to psychopharmacological screening according to the generally accepted scheme, the claimed compounds in a wide range of doses have a pronounced anxiolytic effect, which is not accompanied by side sedative, hypnotic, muscle relaxant effects. The inventive compounds have low toxicity.
RU94022663/04A 1994-06-10 1994-06-10 2-mercaptobenzimidazole derivatives having selective anxiolytic activity RU2061686C1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
RU94022663/04A RU2061686C1 (en) 1994-06-10 1994-06-10 2-mercaptobenzimidazole derivatives having selective anxiolytic activity
DE69528843T DE69528843T2 (en) 1994-06-10 1995-05-11 PHARMACOLOGICALLY ACTIVE 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES
US08/750,369 US6376666B1 (en) 1994-06-10 1995-05-11 2-mercaptobenzimidazole derivatives possessing pharmacological activity
JP50199296A JP3559045B2 (en) 1994-06-10 1995-05-11 2-mercaptobenzimidazole derivatives having pharmacological activity
PCT/RU1995/000085 WO1995034304A1 (en) 1994-06-10 1995-05-11 Pharmacologically active 2-mercaptobenzimidazole derivatives
EP95918794A EP0788795B1 (en) 1994-06-10 1995-05-11 Pharmacologically active 2-mercaptobenzimidazole derivatives
KR1019960707153A KR970703765A (en) 1994-06-10 1996-12-10 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES POSSESSING THE PHARMACOLOGICAL ACTIVITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94022663/04A RU2061686C1 (en) 1994-06-10 1994-06-10 2-mercaptobenzimidazole derivatives having selective anxiolytic activity

Publications (2)

Publication Number Publication Date
RU94022663A true RU94022663A (en) 1996-05-27
RU2061686C1 RU2061686C1 (en) 1996-06-10

Family

ID=20157201

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94022663/04A RU2061686C1 (en) 1994-06-10 1994-06-10 2-mercaptobenzimidazole derivatives having selective anxiolytic activity

Country Status (1)

Country Link
RU (1) RU2061686C1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2423200A1 (en) * 2010-05-26 2012-02-29 Afofarm, Cjsc Polymorphic forms of 5-ethoxy-2-[2-(morpholino)-ethylthio]benzimidazole dihydrochloride and processes for their preparation
RU2519191C1 (en) * 2013-02-19 2014-06-10 Общество с ограниченной ответственностью "Научно-производственное объединение "МедФармСинтез" Medication, possessing anxiolytic activity
RU2578412C1 (en) * 2014-12-02 2016-03-27 Общество С Ограниченной Ответственностью "Валента - Интеллект" Pharmaceutical composition for treating asthenia and/or chronic fatigue syndrome
JP2023526515A (en) 2020-05-20 2023-06-21 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ Methods for treating lysosomal storage diseases with histatin peptides

Also Published As

Publication number Publication date
RU2061686C1 (en) 1996-06-10

Similar Documents

Publication Publication Date Title
MX9707453A (en) Quinazoline derivatives.
MY129540A (en) Quinazoline derivatives, pharmaceutical compositions containing them processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect
SE9504661D0 (en) New compounds
NZ314207A (en) 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
PL328310A1 (en) Derivatives of quinazoline
RU94022258A (en) New sulfonylaminopyrimidines
MX9702382A (en) New pyrimidone derivatives with antifungal activity.
SE9702564D0 (en) New compounds
YU47116B (en) PROCEDURE FOR OBTAINING NEW N-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
ATE247959T1 (en) NON-PEPTIDIC G-CSF MIMETICS
DE68906609D1 (en) DOPAMIN PRECURRENT.
BG96171A (en) AMIDINOPHENYLALALINE DERIVATIVES, METHOD OF THEIR PREPARATION, THEIR APPLICATION AND AGENTS CONTAINING THEM
FR2684103B1 (en) NOVEL COMPOUNDS WITH GUANIDIC STRUCTURE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
UA49089C2 (en) Carbohydrate derivatives and pharmaceutical composition thereof
SE9702563D0 (en) Compounds
ATE81655T1 (en) CEPHEM COMPOUNDS AND PROCESSES FOR THEIR PRODUCTION.
ES2111352T3 (en) USE OF DIESTER PHOSPHATE FOR THE TREATMENT OF RETINAL DISEASES.
TR200201669T2 (en) Substituted piperazine derivatives as MTP inhibitors
RU94022663A (en) Derivatives of 2-mercaptobenzimidazole having selective anxyolytic activity
AR007052A1 (en) A CARBOHYDRATE DERIVATIVE, ITS USE AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
SE9504662D0 (en) New compounds
GB9505082D0 (en) Medicament
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
ATE247903T1 (en) FUNGICIDAL COMPOSITION CONTAINING AN N-BENZOYL-N'-PHENYL-UREA DERIVATIVE
RU95106652A (en) Optically active derivatives of carboxamide, analgetic agent

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Effective date: 20051122

ND4A Extension of patent duration

Free format text: CLAIMS: ê äåéñòâè  ïàòåíòà ïðîäëåí â îòíîøåíèè ï. 1 ôîðìóëû èçîáðåòåíè

QZ4A Changes in the licence of a patent

Effective date: 20040728

QB4A Licence on use of patent

Effective date: 20070817

QZ4A Changes in the licence of a patent

Effective date: 20040512

QZ4A Changes in the licence of a patent

Effective date: 20040728

QZ4A Changes in the licence of a patent

Effective date: 20040512

QB4A Licence on use of patent

Effective date: 20081112

QZ4A Changes in the licence of a patent

Effective date: 20070817

QZ4A Changes in the licence of a patent

Effective date: 20081112

QB4A Licence on use of patent

Free format text: SUB-LICENCE

Effective date: 20101122

QZ41 Official registration of changes to a registered agreement (patent)

Free format text: SUB-LICENCE FORMERLY AGREED ON 20070817

Effective date: 20110719

QB4A Licence on use of patent

Free format text: SUB-LICENCE

Effective date: 20110727

QZ41 Official registration of changes to a registered agreement (patent)

Free format text: SUB-LICENCE FORMERLY AGREED ON 20101122

Effective date: 20110811

PD4A Correction of name of patent owner
QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20040512

Effective date: 20111012

PD4A Correction of name of patent owner
QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20040512

Effective date: 20120808

QB4A Licence on use of patent

Free format text: SUB-LICENCE

Effective date: 20140624

PD4A Correction of name of patent owner
QZ41 Official registration of changes to a registered agreement (patent)

Free format text: SUB-LICENCE FORMERLY AGREED ON 20110727

Effective date: 20160907

QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20040512

Effective date: 20171102